News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Generic Felbamate Now Available from Amneal Pharmaceuticals


9/19/2011 10:24:28 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, LLC is pleased to announce that its generic Felbamate tablets are now available in 400 mg and 600 mg strengths. Amneal’s latest First-to-Market product is an AB-rated, therapeutically equivalent alternative to the antiepileptic drug Felbatol® (a registered trademark of Meda Pharmaceuticals Inc.). Annual U.S. sales of Felbatol® are $43.7 million according to January 2011 IMS Health market data. Amneal received U.S. FDA approval to manufacture Felbamate tablets on September 13, 2011.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES